Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function

Conditions:   Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder CancerInterventions:   Drug: Gemcitabine hydrochloride;   Drug: Paclitaxel;   Drug: Doxorubicin hydrochloride;   Drug: PegfilgrastimSponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)Active, not recruiting - verified September 2014

Source: ClinicalTrials.gov - May 23, 2007 Category: Research Source Type: clinical trials